MedinotecMDNC 24 Net Current Asset Value is $0.45 as of Feb. 2026, which is 97% below its 10-year median of 15.15. GuruFocus rates MDNC with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Medinotec's net current asset value per share for the quarter that ended in Feb. 2026 was $0.45.
The historical rank and industry rank for Medinotec's Net Current Asset Value or its related term are showing as below:
MDNC'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 11.11 Med: 15.15 Max: 33.33
Current: 11.11
During the past 5 years, the highest Price-to-Net-Current-Asset-Value Ratio of Medinotec was 33.33. The lowest was 11.11. And the median was 15.15.
MDNC's Price-to-Net-Current-Asset-Value is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 4.99
vs MDNC: 11.11
Medinotec (OTCPK:MDNC) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Medinotec Net Current Asset Value Related Terms
Medinotec Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Medinotec's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MDNC vs NVNO, APYX, RDGL: Net Current Asset Value Comparison
For the Medical Devices subindustry, Medinotec's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinotec Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medinotec's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Medinotec's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.45 mean?
Medinotec (MDNC) has a Net Current Asset Value of $0.45 as of Feb. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Medinotec and its competitors. This is 97% below median its historical median of 15.15. Over the past decade, Medinotec's Net Current Asset Value has ranged from 11.11 to 33.33.
Is Medinotec's Net Current Asset Value too high?
Medinotec's current Net Current Asset Value of $0.45 is 97% below median its 10-year median of 15.15. Over the past 10 years, this metric has ranged from a low of 11.11 to a high of 33.33. The Medical Devices & Instruments industry median Net Current Asset Value is 4.99. Medinotec's value of $0.45 is 91% below this industry median. Overall, Medinotec has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medinotec's Net Current Asset Value compare to NVNO and APYX?
Medinotec's Net Current Asset Value of $0.45 can be compared against companies in the Medical Devices & Instruments industry. The industry median Net Current Asset Value is 4.99. Medinotec's value of $0.45 is 91% below this benchmark. Historically, Medinotec's own Net Current Asset Value has ranged from 11.11 to 33.33 over the past decade. While the company's 10-year median is 15.15 vs. the industry median of 4.99, Medinotec has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.99, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinotec's current Net Current Asset Value of $0.45 is 91% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Medinotec and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinotec's current Net Current Asset Value is $0.45, which is 97% below median its own 10-year median of 15.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinotec stock overvalued right now?
Medinotec (MDNC) has a current Net Current Asset Value of $0.45. The current Net Current Asset Value is $0.45, which is 97% below median its 10-year median of 15.15 and 91% below the Medical Devices & Instruments industry median of 4.99. Medinotec's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Medinotec (MDNC), the current Net Current Asset Value is $0.45 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.
24GF Score
Get the complete analysis for MDNC
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDNC has been successfully added to your 
